The Cancer Genome Atlas team reports in Nature on its study of 178 lung squamous cell carcinomas in which it found that such tumors are marked by complex genomic changes like rearrangements and copy number alterations. The TCGA team also notes that it found recurrent mutations in most samples, including TP53 mutations, and a number of pathways that are affected by those mutations. Further, the team reports that, for most tumors, it could identify potential therapeutic targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.